{
    "clinical_study": {
        "@rank": "134487", 
        "acronym": "PAC-IC-SAOS", 
        "arm_group": [
            {
                "arm_group_label": "OSA/CPAP", 
                "arm_group_type": "Experimental", 
                "description": "OSA patients intervention : CPAP treatment"
            }, 
            {
                "arm_group_label": "OSA/sham CPAP", 
                "arm_group_type": "Sham Comparator", 
                "description": "OSA patients intervention : Sham CPAP treatment"
            }, 
            {
                "arm_group_label": "control group", 
                "arm_group_type": "No Intervention", 
                "description": "Patients without any apnea syndrome"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this clinical trial is to evaluate the effect of obstructive sleep apnea syndrome\n      (OSAS)  treatment in heart failure patients following coronary artery bypass graft (CABG)\n      surgery."
        }, 
        "brief_title": "PAC-IC-SAOS Obstructive Sleep Apnea Syndrome and Ventricular Function", 
        "completion_date": {
            "#text": "April 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Heart Failure", 
            "Arteriosclerosis of Coronary Artery Bypass Graft", 
            "Sleep Apnea, Obstructive"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Arteriosclerosis", 
                "Heart Failure", 
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "This clinical trial is a double-blind, randomized, placebo-controlled study.\n\n      The first objective is to evaluate the influence of continuous positive airway pressure\n      (CPAP) treatment for OSAS on the ventricular function improvement in heart failure patients,\n      in comparison with OSA patients treated with sham CPAP. This treatment will be instaurated\n      just after CABG surgery\n\n      Secondary objectives :\n\n        -  Evaluation of the effect of CPAP treatment on the endothelial function\n\n        -  Evaluation of the effect of CPAP treatment on systemic inflammation\n\n        -  Evaluation of the effect of CPAP treatment on oxidative stress,\n\n        -  Evaluation of the effect of CPAP treatment on insulin resistance,\n\n      after the CABG surgery, in comparison with OSA patients treated with sham CPAP and non\n      apneic control patients, with heart failure.\n\n        -  Assessment of the impact of nocturnal desaturation level on the vascular reactivity and\n           atherosclerosis of mammary vessels collected during surgery.\n\n        -  Assessment of the impact of nocturnal desaturation level on the oxidative stress,\n           inflammation and insulin sensitivity on abdominal and epicardiac adipose tissue\n           collected during surgery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Coronary Artery Bypass Surgery\n\n          -  Heart failure patient: with visual LVEF <45% by echocardiogram\n\n        Exclusion Criteria:\n\n          -  Aortic or mitral valvular replacement\n\n          -  Aortic surgery\n\n          -  Triple stimulator implanted less than 6 months ago\n\n          -  Patient already treated for a SAOS syndrome\n\n          -  Patient with a central sleep apnea syndrome\n\n          -  Patient with malignant evolutive pathology\n\n          -  Pregnant or lactating women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "69", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01900379", 
            "org_study_id": "1310", 
            "secondary_id": "2013-A00543-42"
        }, 
        "intervention": [
            {
                "arm_group_label": "OSA/CPAP", 
                "description": "This device consists in a nasal continuous positive airway pressure. It will be applied just after CABG and for 3 months for OSA/CPAP patients group.", 
                "intervention_name": "CPAP treatment", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "OSA/sham CPAP", 
                "description": "This device consists in a sham continuous positive airway pressure. It will be applied just after CABG and for 3 months for OSA/sham CPAP patients group.", 
                "intervention_name": "Sham CPAP treatment", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Obstructive sleep apneas syndrome", 
            "Continuous positive airway pressure treatment", 
            "Heart failure", 
            "Coronary artery bypass graft surgery"
        ], 
        "lastchanged_date": "November 28, 2013", 
        "location": {
            "contact": {
                "email": "RTamisier@chu-grenoble.fr", 
                "last_name": "Renaud TAMISIER, MD, PhD", 
                "phone": "33-476-765-516"
            }, 
            "facility": {
                "address": {
                    "city": "Grenoble", 
                    "country": "France", 
                    "zip": "38000"
                }, 
                "name": "University Hospital of Grenoble"
            }, 
            "investigator": [
                {
                    "last_name": "Sandrine LAUNOIS-ROLLINAT, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Patrick LEVY, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jean-Louis PEPIN, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Vincent BACH, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Olivier CHAVANON, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Rachid HACINI, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Paolo PORCU, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jean-Philippe BAGUET, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Gilles BARONE-ROCHETTE, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Carole SAUNIER, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "C\u00e9cile ROCCA, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Patrice FAURE, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Fran\u00e7oise STANKE, PharmD, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "3", 
        "official_title": "Impact of the Obstructive Sleep Apnea Syndrome Treatment and Ventricular Function in Heart Failure Patients Undergoing Coronary Artery Bypass Surgery", 
        "overall_contact": {
            "email": "RTamisier@chu-grenoble.fr", 
            "last_name": "Renaud TAMISIER, MD, PhD", 
            "phone": "33-476-765-516"
        }, 
        "overall_official": {
            "affiliation": "University Hospital of Grenoble, France", 
            "last_name": "Renaud TAMISIER, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement of the left ventricular ejection fraction by a cardiac ultrasonography", 
            "measure": "Percent of ventricular function recovery (left ventricular ejection fraction (LVEF)) improvement conferred by CPAP post-operative treatment", 
            "safety_issue": "Yes", 
            "time_frame": "After 3 months of CPAP post-operative treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01900379"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measurement of peripheral arterial tone", 
                "measure": "Assessment of CPAP effect on the endothelial function, after the surgery in comparison with sham CPAP treated patient with heart failure and OSAS.", 
                "safety_issue": "Yes", 
                "time_frame": "After 3 months of CPAP post-operative treatment"
            }, 
            {
                "description": "Measurement of pulse wave velocity", 
                "measure": "Assessment of CPAP effect on the endothelial function, after the surgery in comparison with sham CPAP treated patient with heart failure and OSAS.", 
                "safety_issue": "Yes", 
                "time_frame": "After 3 months of CPAP post-operative treatment"
            }, 
            {
                "description": "By immunological and histological analysis of mammary vessels", 
                "measure": "Assessment of the impact of nocturnal desaturation level on the vascular atherosclerosis of mammary vessels collected during surgery.", 
                "safety_issue": "Yes", 
                "time_frame": "Sleep disordered breathing level, 2 months before surgery"
            }, 
            {
                "description": "Measuring inflammatory and oxidative adipose markers", 
                "measure": "Assessment of the impact of nocturnal desaturation level on the oxidative stress, inflammation and insulin sensitivity of the abdominal and epicardiac adipose tissue collected during surgery.", 
                "safety_issue": "Yes", 
                "time_frame": "Sleep disordered breathing level, 2 months before surgery"
            }, 
            {
                "description": "By immunological and histological analysis of abdominal and epicardiac adipose tissue", 
                "measure": "Assessment of the impact of nocturnal desaturation level on the vascular reactivity of mammary vessels collected during surgery.", 
                "safety_issue": "Yes", 
                "time_frame": "Sleep disordered breathing level, 2 months before surgery"
            }, 
            {
                "description": "Measurement of inflammatory and oxidative serum markers", 
                "measure": "Assessment of CPAP effect on the systemic inflammation and oxidative stress, the insulin resistance, after the surgery in comparison with sham CPAP treated patients with heart failure and OSAS.", 
                "safety_issue": "Yes", 
                "time_frame": "After 3 months of CPAP post-operative treatment"
            }
        ], 
        "source": "University Hospital, Grenoble", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Grenoble", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}